
Chairman, President & CEO CyroPort, Inc.
Greater San Diego Area

Chairman, President & CEO CyroPort, Inc.
Greater San Diego Area
A tough-minded executive known for visionary leadership in high growth and under performing businesses. Larry G Stambaugh is a principal at Apercu Consulting, where he serves as an advisor to private and public boards and management, including clean tech and life sciences companies. He is the Chairman of the Board, President & CEO of Cryoport, Chairman of Ridge Diagnostics and Director at EcoDog. Is is also the former Chief Executive Officer and President of Calando Pharmaceuticals, Inc,, co-founder, Chairman & CEO of Maxim Pharmceuticals, and the Chairman & CEO of ABC Laboratories,. During his more than 35-year career Mr. Stambaugh has served as a top executive and his visionary leader has built management teams and companies around “A humble heart and an open mind”. He has led the turnaround of organizations through setting strategic initiatives with the board and management for new directions and priorities. His well developed process has effectively guided the board and management to realistically access their strengths and weakness and direct the organization into new businesses and discontinue underperforming activities and business units. Mr. Stambaugh has raised nearly $400 million of capital in private and public financing. He has taken a company public in both the U.S. and Europe. In times of weak financing markets he has found creative alternatives for financing including, PIPE transactions, syndicated bank loans, reverse mergers, corporate collaborations and private equity funding.
Mr. Stambaugh has had a focus on board activities and corporate governance practices for nearly three decades. He has more nearly 100 years of board service and speaks on the best practices and current issues in corporate governance. In 2002, 2006 and for an unprecedented third time in 2007 he was awarded the “Director of the Year” recognition for his work in corporate governance leadership and education.
Experienced top executive in a clean tech, life sciences company, contract research services company, equipment manufacturer, retail sales company, mulit- bank commercial banking company and business consulting
(Biotechnology industry)
February 2009 — Present (6 months)
Cryoport is a public company that is commercializing a revolutionary approach to frozen shipments that will eliminate dry ice and improve the integrity of shipments arriving in tact.
(Environmental Services industry)
March 2008 — Present (1 year 5 months)
EcoDog is commercializing a product to reduce electrical usage in homes by 15 - 30 % and it is a product that will be cash flow positive to the homeowner from the first day.
(Biotechnology industry)
February 2008 — Present (1 year 6 months)
A co-founder of Ridge Diagnostics, a company that is commercializing a first ever blood test for Major Depressive Disorder. It is a breakthrough because there has never been a blood test for any neurological disease. It is believed that this may significantly advance the management and treatment of patients with depression.
(Environmental Services industry)
February 2006 — Present (3 years 6 months)
Serves as an advisor to several private and public boards and CEOs, concentrating on strategic business direction, turnarounds and board governance. Currently working with clean tech and life science teams to help them raise capital, reach their highest levels of achievement, uncover sensitive issues and generate superior options for action. Using 30+ years of successful problem solving and leadership to bring clarity and help focus teams on facing and conquering the tough challenges, including appropriately defining themselves, gaining financing, and driving products to the market.
(Environmental Services industry)
January 2006 — Present (3 years 7 months)
As a mentor to emerging companies, work with other seasoned executives to help young companies move toward funding, marketing and advancing their young companies.
(Environmental Services industry)
2006 — Present (3 years)
(Biotechnology industry)
February 1998 — Present (11 years 6 months)
A trade organization for the life sciences industry in Southern California. I lead the organizations political policy committee and serve as board lead on the strategic planning committee.
(Non-Profit Organization Management industry)
September 1994 — Present (14 years 11 months)
An organization for the education of corporate directors to help them become better directors. I have been the past Chairman of the organization, have been awarded "Director of the Year" recognition an unprecedented three times, and founded and lead the national conference - Directors Forum.
(Environmental Services industry)
2007 — 2008 (1 year)
A company commercializing an innovative carrier for mRNA technology in multiple indications.
(Public Company; Biotechnology industry)
December 1992 — January 2006 (13 years 2 months)
Raised over $350 million including private equity, IPO in the U.S and follow-on secondary and PIPE transactions. Listed company on public markets in Europe while growing market capitalization from $15 million to $1.5 billion.
Prepared initial business plan, assembled highly experienced management team and acquired technologies in cancer and liver disease.
Conducted 17 clinical trials in 20 countries on three continents, and presented complex science to and negotiated strategic partnerships with Fortune 100 pharmaceutical companies.
Divested of diagnostic division and acquired exclusive worldwide rights to apoptosis technologies through the acquisition of a biotechnology company.
Identified and completed a strategic transaction to merge Maxim with a New Jersey biotech company after the Company had negative clinical trial results and FDA delays.
(Environmental Services industry)
1989 — 1992 (3 years)
Recruited to restructure an international environmental services and instrument manufacturing company with growing pains and significant customer service issues. The top priorities were to take advantage of a growing market, provide capital for expansion, and assemble a management team and leading scientists to serve Fortune 500 customers.
• Doubled sales from $9.7 million to $21 million, achieved record earnings, and returned over 20% on beginning equity.
• Attracted and hired over 200 new associates, including renowned world leaders in environmental science and many advanced degree scientists.
• Instituted intensive training program to develop management skills, communication abilities, integration of new associates into Company, and focus on quality concepts.
• Directed company’s offshore expansion, resulting in over 25% of sales from Europe and Pacific Rim.
BBA , Accounting / Finance , 1965 — 1969
Clean technology, innovation, corporate governance, golf, photography, travel,
Three time awardee of Corporate Director of the Year Award, San Diego Technology Fast 50 Company Award, CONNECT Most Innovative Product Award, Honorary Chairman - American Liver Foundation Annual Dinner, and Community Caring Award - Billy Foundation, Distinguished Jim McGraw Award in life sciences, Who's Who In the World, America and Finance for multiple years
Frequent speaker in over 50 publications and meetings on corporate governance and executive leadership.